Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Katz

Showing results (571-580 of 749) with videos related to

Pageof 75
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|April 18, 2014
Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?David R Fogelman, Holly Holmes, Khalil Mohammed, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 27, 2007
Cytokine--chemokine and apoptotic signatures in patients with hepatitis CManuela G Neuman, Jean-Pierre Benhamou, Patrick Marcellin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice GuidelineAlok A Khorana, Pamela B Mangu, Jordan Berlin, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 24, 2015
After Pancreatectomy, the “90 Days from Surgery” Definition Is Superior to the “30 Days from Discharge” Definition for Capture of Clinically Relevant ReadmissionsYoshihiro Mise, Ryan W Day, Jean-Nicolas Vauthey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 28, 2019
AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis by Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI AxisMalik Bisserier, Javier Milara, Yassine Abdeldjebbar, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 4, 2018
Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimizationRebecca A Snyder, Laura R Prakash, Graciela M Nogueras-Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2017
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateAlok A Khorana, Pamela B Mangu, Jordan Berlin, et al.
Pancreas|December 12, 2025
Presentation, Management, and Outcomes of Cyst-Associated Pancreatic Cancer versus Classic Pancreatic Ductal AdenocarcinomaTimothy E Newhook, Michael P Kim, Belkacem Acidi, et al.
Annals of Surgical Oncology|August 10, 2012
Fear of cancer recurrence after curative pancreatectomy: a cross-sectional study in survivors of pancreatic and periampullary tumorsMaria Q B Petzel, Nathan H Parker, Alan D Valentine, et al.
JCO Oncology Practice|July 7, 2026
Availability and Use of Social Determinants of Health Data in Alliance Gastrointestinal Cancer Clinical TrialsKever A Lewis, Brian A Colgrove, Garth D Nelson, et al.
Pageof 75

Showing results (571-580 of 749) with videos related to

Sort By:
Pageof 75
Journal of Cachexia, Sarcopenia and Muscle|April 18, 2014
Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?David R Fogelman, Holly Holmes, Khalil Mohammed, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 27, 2007
Cytokine--chemokine and apoptotic signatures in patients with hepatitis CManuela G Neuman, Jean-Pierre Benhamou, Patrick Marcellin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice GuidelineAlok A Khorana, Pamela B Mangu, Jordan Berlin, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 24, 2015
After Pancreatectomy, the “90 Days from Surgery” Definition Is Superior to the “30 Days from Discharge” Definition for Capture of Clinically Relevant ReadmissionsYoshihiro Mise, Ryan W Day, Jean-Nicolas Vauthey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 28, 2019
AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis by Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI AxisMalik Bisserier, Javier Milara, Yassine Abdeldjebbar, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 4, 2018
Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimizationRebecca A Snyder, Laura R Prakash, Graciela M Nogueras-Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2017
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateAlok A Khorana, Pamela B Mangu, Jordan Berlin, et al.
Pancreas|December 12, 2025
Presentation, Management, and Outcomes of Cyst-Associated Pancreatic Cancer versus Classic Pancreatic Ductal AdenocarcinomaTimothy E Newhook, Michael P Kim, Belkacem Acidi, et al.
Annals of Surgical Oncology|August 10, 2012
Fear of cancer recurrence after curative pancreatectomy: a cross-sectional study in survivors of pancreatic and periampullary tumorsMaria Q B Petzel, Nathan H Parker, Alan D Valentine, et al.
JCO Oncology Practice|July 7, 2026
Availability and Use of Social Determinants of Health Data in Alliance Gastrointestinal Cancer Clinical TrialsKever A Lewis, Brian A Colgrove, Garth D Nelson, et al.
Pageof 75